STANDARD BIOTOOLS INC. 10-Q

Item 5. Other Information None. 78 Item 6. Exhibits The documents listed in the Exhibit List, which follows below, are incorporated by reference or are filed with this quarterly report on Form 10-Q, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K). EXHIBIT LIST Exhibit Number Description Incorporated by Reference From Form Incorporated by Reference From Exhibit Number Date Filed 3.1 Eighth Amended and Restated Certificate of Incorporation filed on February 15, 2011. 10-K 3.1 3/28/2011 3.2 Amended and Restated Bylaws of Standard BioTools Inc. S-8 4.8 4/1/2022 3.3 Certificate of Amendment to the Eighth Amended and Restated Certificate of Incorporation. S-8 4.3 4/1/2022 3.4 Certificate of Designation of Rights, Preferences and Privileges of Series A Participating Preferred Stock. 8-K 3.1 11/22/2016 3.5 Certificate of Elimination of Series A Participating Preferred Stock. 8-K 3.1 8/2/2017 3.6 Certificate of Designations of Rights, Preferences and Privileges of Series B-1 Convertible Preferred Stock. 8-K 3.6 4/5/2022 3.7 Certificate of Designations of Rights, Preferences and Privileges of Series B-2 Convertible Preferred Stock. 8-K 3.7 4/5/2022 10.1 Sublease, dated as of August 30, 2022, between Standard BioTools Inc. and CIRC Bio, Inc. Filed herewith 31.1 Certification Pursuant to Rule 13a-14(a)/15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of Chief Executive Officer. Filed herewith 31.2 Certification Pursuant to Rule 13a-14(a)/15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of Chief Financial Officer. Filed herewith 32.1 (1) Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 of Chief Executive Officer. Filed herewith 32.2 (1) Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 of Chief Financial Officer. Filed herewith 101.INS Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. Filed herewith 101.SCH Inline XBRL Taxonomy Extension Schema Document Filed herewith 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document Filed herewith 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document Filed herewith 101.LAB Inline XBRL Taxonomy Extension Label Document Filed herewith 101.PRE Inline XBRL Taxonomy Extension Presentation Document Filed herewith 104 Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101). Filed herewith (1) In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 33-8238 and 34-47986, Final Rule: Management’s Report on Internal Control Over Financial Reporting and Certification of Disclosure in Exchange Act Periodic Reports, the certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates them by reference. 79 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. STANDARD BIOTOOLS INC. Dated: November 9, 2022 By: /s/ Michael Egholm Michael Egholm Chief Executive Officer and President (Principal Executive Officer) Dated: November 9, 2022 By: /s/ Vikram Jog Vikram Jog Chief Financial Officer (Principal Accounting and Financial Officer)